There are almost 120 different types of phytocannabinoids found within the cannabis plant. Each cannabinoid has their own unique properties, such as psychoactive effects on the mind or an antidepressant effect. New cannabinoids are being discovered every year around the world. In 2019, a team of researchers from Italy found a new cannabinoid and have named it Delta 9 Tetrahydrocannabutol (THCB).
THCB is closely related to Delta 9, which is the main psychoactive cannabinoid in cannabis. It’s what causes the euphoric high consumers aim for when they take cannabis and Delta 9 products. Because of it’s recent discovery as an individual cannabinoid, there is little research on how THCB effects people. But here is what scientists have discovered about this new cannabinoid.
THCB is a phytocannabinoid. It’s a cannabinoid that comes from the cannabis plant. Compare this to endocannabinoids that are found within animals. This cannabinoid is similar to Delta 9 in how it interacts with the cannabinoid receptors in the brain. These receptors are CB1 and CB2. THCB has a higher binding affinity with CB1 over standard Delta 9. This is one of the major differences between these two similar cannabinoids.
Small animal tests were conducted after the THCB cannabinoid was discovered. They show it created some of the same effects in mice as it did in humans. These effects include: pain decrease, slowed reaction time, and increased sleep. THCB also showed possible analgesic and anti-inflammatory properties.
Alongside THCB, that same group of Italian researchers discovered THCP. This cannabinoid also creates some of the same effects as Delta 9 THC and THCB. There seems to be more research on THCP over THCB. But that doesn’t mean much when there isn’t much available at all. The research was published online in a scientific journal called Nature. It breaks down the exact process the researchers used to identify both THCP and THCB.
Researchers go on to state that it is possibly THCP, with some THCB aspects, that could be causing the psychoactive effects in cannabis users over Delta 9 THC, which is what scientists have been saying for years. While disputed by other scientists, more research needs to happen before definitive answers are made. With cannabis still considered a Schedule I drug by the DEA, cannabis and hemp research is left to scientists outside of the US to make breakthroughs.
Once more information is is available, we will update you with the latest. Make sure to check back for more cannabis and hemp related news.